Performance Analysis of Six Semi-Automated Tumour Delineation Methods on [18F] Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography (FDG PET/CT) in Patients with Head and Neck Cancer

被引:2
|
作者
Bianconi, Francesco [1 ]
Salis, Roberto [2 ]
Fravolini, Mario Luca [1 ]
Khan, Muhammad Usama [1 ]
Minestrini, Matteo [3 ]
Filippi, Luca [4 ]
Marongiu, Andrea [2 ]
Nuvoli, Susanna [2 ]
Spanu, Angela [2 ]
Palumbo, Barbara [3 ]
机构
[1] Univ Perugia, Dept Engn, Via Goffredo Duranti 93, I-06125 Perugia, Italy
[2] Univ Sassari, Dept Med Surg & Pharm, Unit Nucl Med, I-07100 Sassari, Italy
[3] Univ Perugia, Sect Nucl Med & Hlth Phys, Dept Med & Surg, Piazza Lucio Severi 1, I-06132 Perugia, Italy
[4] Policlin Tor Vergata Hosp, Viale Oxford 81, I-00133 Rome, Italy
关键词
head and neck cancer; positron emission tomography; segmentation; region of interest; radiomics; RADIOMICS; PREDICTION; SEGMENTATION; VOLUME; IMPACT;
D O I
10.3390/s23187952
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
Background. Head and neck cancer (HNC) is the seventh most common neoplastic disorder at the global level. Contouring HNC lesions on [F-18] Fluorodeoxyglucose positron emission tomography/computed tomography (FDG PET/CT) scans plays a fundamental role for diagnosis, risk assessment, radiotherapy planning and post-treatment evaluation. However, manual contouring is a lengthy and tedious procedure which requires significant effort from the clinician. Methods. We evaluated the performance of six hand-crafted, training-free methods (four threshold-based, two algorithm-based) for the semi-automated delineation of HNC lesions on FDG PET/CT. This study was carried out on a single-centre population of n = 103 subjects, and the standard of reference was manual segmentation generated by nuclear medicine specialists. Figures of merit were the Sorensen-Dice coefficient (DSC) and relative volume difference (RVD). Results. Median DSC ranged between 0.595 and 0.792, median RVD between -22.0% and 87.4%. Click and draw and Nestle's methods achieved the best segmentation accuracy (median DSC, respectively, 0.792 +/- 0.178 and 0.762 +/- 0.107; median RVD, respectively, -21.6% +/- 1270.8% and -32.7% +/- 40.0%) and outperformed the other methods by a significant margin. Nestle's method also resulted in a lower dispersion of the data, hence showing stronger inter-patient stability. The accuracy of the two best methods was in agreement with the most recent state-of-the art results. Conclusions. Semi-automated PET delineation methods show potential to assist clinicians in the segmentation of HNC lesions on FDG PET/CT images, although manual refinement may sometimes be needed to obtain clinically acceptable ROIs.
引用
收藏
页数:15
相关论文
共 50 条
  • [41] The Role of F-Fluorodeoxyglucose (FDG) Positron Emission Tomography–Computed Tomography (PET/CT) in the Screening of Cervical Cancer: A Literature Review
    Fengjun Guo
    Ruiqi Yang
    Jingyan Tian
    Limei Fan
    Cell Biochemistry and Biophysics, 2014, 69 : 197 - 201
  • [42] Circulating tumor cells (CTC), [18F]fluorodeoxyglucose positron emission tomography, and computed tomography (PET/CT) for treatment monitoring in patients with metastatic breast cancer (MBC)
    Tamkus, D.
    Chandana, S. R.
    Berger, K.
    Aung, T.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [43] Oncocytic carcinoid tumor of the lung with intense F-18 fluorodeoxyglucose (FDG) uptake in positron emission tomography–computed tomography (PET/CT)
    Yuki Tanabe
    Yoshifumi Sugawara
    Rieko Nishimura
    Kohei Hosokawa
    Makoto Kajihara
    Teruhiko Shimizu
    Tadaaki Takahashi
    Shinya Sakai
    Shigeki Sawada
    Motohiro Yamashita
    Haruhiko Ohtani
    Annals of Nuclear Medicine, 2013, 27 : 781 - 785
  • [44] Primary mediastinal extraskeletal osteosarcoma on 18F-fluorodeoxyglucose (FDG) positron emission tomography/ computed tomography (PET/CT): a case description
    Yang, Zhimin
    Wang, Jianfeng
    Feng, Jinbao
    Shi, Yunmei
    Wang, Yuetao
    Niu, Rong
    QUANTITATIVE IMAGING IN MEDICINE AND SURGERY, 2024, 14 (09) : 7004 - 7011
  • [45] USE OF 18F-FLUORODEOXYGLUCOSE (FDG) POSITRON EMISSION TOMOGRAPHY/COMPUTED TOMOGRAPHY (PET/CT) FOR DIAGNOSING PROSTHETIC VALVE PERIVALVULAR ABSCESS
    Weber, Brittany
    Galazka, Patrycja
    Steinhauser, Matthew
    Dorbala, Sharmila
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 69 (11) : 2122 - 2122
  • [46] Imaging and quantification of atherosclerotic plaque by [18F] fluorodeoxyglucose positron emission tomography (FDG-PET)
    Rudd, J
    Fryer, T
    Warburton, E
    Clark, J
    Jones, H
    Graves, M
    Gillard, J
    Davenport, A
    Johnstrom, P
    Kirkpatrick, P
    Pickard, J
    Weissberg, P
    HEART, 2003, 89 : A48 - A48
  • [47] Contribution of 18F fluorodeoxyglucose positron emission tomography (FDG-PET) in the management of anal carcinoma
    Renaud, S.
    Guillemard, S.
    Eberle-Pouzeratte, M-C.
    Lemanski, C.
    Faurous, P.
    Artus, J-C.
    MEDECINE NUCLEAIRE-IMAGERIE FONCTIONNELLE ET METABOLIQUE, 2009, 33 (07): : 415 - 424
  • [48] Evaluation of 18F-fluorodeoxyglucose positron emission tomography and computed tomography with histopathologic correlation in the initial staging of head and neck cancer
    Hannah, A
    Scott, AM
    Tochon-Danguy, H
    Chan, JG
    Akhurst, T
    Berlangieri, S
    Price, D
    Smith, GJ
    Schelleman, T
    McKay, WJ
    Sizeland, A
    ANNALS OF SURGERY, 2002, 236 (02) : 208 - 217
  • [49] Impact of 18F-fluorodeoxyglucose (FDG)-positron-emission tomography/computed tomography (PET/CT) on management of patients with carcinoma invading bladder muscle
    Mertens, Laura S.
    Fioole-Bruining, Annemarie
    Vegt, Erik
    Vogel, Wouter V.
    van Rhijn, Bas W.
    Horenblas, Simon
    BJU INTERNATIONAL, 2013, 112 (06) : 729 - 734
  • [50] Characterization of pulmonary lesions in patients with suspected lung cancer: computed tomography versus [18F]fluorodeoxyglucose-positron emission tomography/computed tomography
    Harders, Stefan Walbom
    Madsen, Hans Henrik
    Hjorthaug, Karin
    Arveschoug, Anne Kirstine
    Rasmussen, Torben Riis
    Meldgaard, Peter
    Andersen, Johanne Bach
    Pilegaard, Hans Kristian
    Hager, Henrik
    Rehling, Michael
    Rasmussen, Finn
    CANCER IMAGING, 2012, 12 (03): : 437 - 446